Nephros (NEPH) Income towards Parent Company (2010 - 2026)
Nephros' (NEPH) quarterly Income towards Parent Company came in at $29000.0 in Q1 2026, up 103.23% year-on-year from $14269.8 in Q1 2025, and down 53.23% quarter-over-quarter from $62000.0 in Q4 2025.
Nephros (NEPH) Income towards Parent Company (2010 - 2026) Analysis & Trends
Nephros' Income towards Parent Company history runs 17 years deep, the most recent figure standing at $29000.0 for Q1 2026.
- On a quarterly basis, Income towards Parent Company rose 103.23% year-over-year to $29000.0 in Q1 2026; TTM through Mar 2026 was $665000.0, a 203.74% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 1513.51% from the prior year.
- Income towards Parent Company retreated to $29000.0 in Q1 2026 per NEPH's latest filing, from $62000.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at $364000.0 in Q4 2024 and bottomed at -$1.0 million in Q3 2023.
- The 5-year median for Income towards Parent Company is -$289000.0 (2024), against an average of -$243705.9.
- Across the five-year window, Income towards Parent Company jumped 182.73% in 2024 and slumped 332.21% in 2025, its largest moves.
- Year by year, Income towards Parent Company stood at -$129000.0 in 2022, then tumbled by 241.09% to -$440000.0 in 2023, then soared by 182.73% to $364000.0 in 2024, then slumped by 82.97% to $62000.0 in 2025, then plunged by 53.23% to $29000.0 in 2026.
- Per Business Quant, the three latest NEPH Income towards Parent Company figures stand at $29000.0 (Q1 2026), $62000.0 (Q4 2025), and $337000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.91 Bn | 120.70 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.75 Bn | 43.93 Bn | 2.15 Bn |
| 3 | Alcon | 32.94 Bn | 31.28 Bn | 1.53 Bn |
| 4 | Medline | 32.84 Bn | 30.60 Bn | 1.84 Bn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.60 Bn | 23.16 Bn | 329.20 Mn |
| 7 | Solventum | 14.01 Bn | 13.45 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.76 Bn | 13.62 Bn | 735.40 Mn |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn |
| 10 | Nephros | 36.20 Mn | 32.18 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 337,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | -899,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Jun 30, 2024 | -289,000.00 |
| Mar 31, 2024 | -208,000.00 |
| Dec 31, 2023 | -440,000.00 |
| Sep 30, 2023 | -1.03 Mn |
| Jun 30, 2023 | -590,000.00 |
| Mar 31, 2023 | -462,000.00 |
| Dec 31, 2022 | -129,000.00 |
| Sep 30, 2022 | -509,000.00 |
| Jun 30, 2022 | -390,000.00 |
| Mar 31, 2022 | -406,000.00 |
| Dec 31, 2021 | -317,000.00 |
| Sep 30, 2021 | -360,000.00 |
| Jun 30, 2021 | -1.15 Mn |